Article ISI
BIOORGANIC MEDICINAL CHEMISTRY LETTERS  (1997)

Benzothiadiazine dioxide acyclonucleosides as lead compounds for the development of new agents against human cytomegalovirus and varicella-zoster virus infections

Martinez, A; Esteban, AI; DeClercq, E

Abstract

The first acyclonucleosides derived from 2,1,3-benzothiadiazine dioxides were synthesized. From their antiviral activity evaluation results these compounds might be considered as new leads in the search for inhibitors of human cytomegalovirus (CMV) and varicella-zoster virus (VZV) infections. (C) 1997 Elsevier Science Ltd.

Más información

Título según WOS: ID WOS:A1997WY45300017 Not found in local WOS DB
Título de la Revista: BIOORGANIC MEDICINAL CHEMISTRY LETTERS
Volumen: 7
Número: 8
Editorial: PERGAMON-ELSEVIER SCIENCE LTD
Fecha de publicación: 1997
Página de inicio: 1031
Página final: 1032
DOI:

10.1016/S0960-894X(97)00149-2
Notas: ISI